Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Paxmedica Inc
(NQ:
PXMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Paxmedica Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Announces Pricing of $7M Public Offering
November 20, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Crude Oil Gains Over 2%; PaxMedica Shares Plunge
November 20, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why PaxMedica Stock (PXMD) Is Down Nearly 40% Today
November 20, 2023
PaxMedica, Inc. (NASDAQ: PXMD) shares are trading lower by 38% to $1.09 Monday morning. The company on Monday disclosed the pricing details for its public offering.
Via
Benzinga
US Stocks Rise; Nasdaq Gains Over 50 Points
November 20, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 50 points on Monday. Following the market opening Monday, the Dow traded up 0.12% to 34,988.28 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With PaxMedica Stock Today?
November 14, 2023
PaxMedica, Inc. (NASDAQ: PXMD) shares are trading higher on Tuesday. The stock has been volatile over the past month.
Via
Benzinga
PaxMedica Announces Pricing of $7.0 Million Public Offering
November 20, 2023
Via
ACCESSWIRE
Study Examines Role of African Sleeping Sickness in Body Wasting
November 17, 2023
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Syndicated Audio Broadcast
November 17, 2023
Via
Investor Brand Network
Exposures
Product Safety
Why Gap Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
November 17, 2023
Shares of The Gap, Inc. (NYSE: GPS) jumped in pre-market trading after the company reported better-than-expected financial results for the third quarter on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
November 17, 2023
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
November 16, 2023
Via
Benzinga
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Releases Q3 2023 Financial Report, Corporate Update
November 16, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
November 15, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 14, 2023
Via
Benzinga
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
PaxMedica Inc. (NASDAQ: PXMD) Is Hoping to Boost Patient Independence with Potential ASD Treatment Amid Growing Prevalence Rates
November 14, 2023
Via
Investor Brand Network
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
November 14, 2023
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 14, 2023
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) CMO Featured in Latest Bell2Bell Podcast Release
November 09, 2023
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 08, 2023
Via
Benzinga
What's Going On With PaxMedica (PXMD) Stock Today?
November 08, 2023
PaxMedica Inc (NASDAQ: PXMD) shares are trading lower by 11% to $4.00 Wednesday morning, pulling back following Tuesday's strength. The company on Tuesday announced research findings in the Annals of...
Via
Benzinga
Study Finds Autism Compromises Sleep Quality, Physical Activity in Kids
November 07, 2023
Via
Investor Brand Network
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Phase 2 Study Results Published in Peer-Reviewed Journal
November 07, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 07, 2023
Via
Benzinga
Why Is TransMedics (TMDX) Stock Up 53% Today?
November 07, 2023
TransMedics stock is taking off on Tuesday as TMDX investors react to strong revenue and a guidance increase in its Q3 earnings report.
Via
InvestorPlace
Why Is PaxMedica (PXMD) Stock Up 95% Today?
November 07, 2023
PaxMedica stock is taking off with heavy trading of PXMD shares following positive results from a Phase 2 clinical trial.
Via
InvestorPlace
Why PaxMedica (PXMD) Stock Is Up Over 100% Today
November 07, 2023
PaxMedica Inc (NASDAQ: PXMD) shares are trading higher by 175% to $8.39 Tuesday morning after the company announced research findings in the Annals of General Psychiatry regarding a study on low-dose...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.